MedPath

Drainage Amount for Removal of Thoracostomy Tube

Not Applicable
Completed
Conditions
Pneumothorax
Pleural Effusion
Interventions
Other: Drainage <2 mL/kg
Other: No drainage threshold
Registration Number
NCT00575198
Lead Sponsor
University of California, Davis
Brief Summary

The purpose of this study is to determine whether chest tubes can be safely removed without considering how much fluid is draining through the tube.

Detailed Description

Thoracostomy tubes are routinely used to drain the pleural space of fluid and gas to optimize pulmonary mechanics. Clinicians frequently postpone removal of thoracostomy tubes if the drainage from the tube exceeds a specific volume threshold for the prior 24 hours. However, there is substantial variability in the drainage volume threshold that different clinicians use, and no threshold has been established as clearly superior to any other. Removing tubes independently of the drainage volume may result in a greater risk of pleural effusion or pneumothorax requiring an invasive drainage procedure. However, removing tubes independently of the drainage volume might also expedite recovery by allowing earlier removal of the tube, thus diminishing pain and increasing patient mobility.

Thoracostomy tube management practices, including the drainage volume threshold used, may be dissimilar for different types of disease processes, so this study will be restricted to patients who required a thoracostomy tube for treatment of traumatic injury.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
280
Inclusion Criteria
  • Thoracostomy tube in place for <72 hours
  • Age at least 14 years
  • Hospitalized for traumatic injury or elective operation
Exclusion Criteria
  • Thoracostomy tube already removed from the pleural cavity of interest
  • Mediastinal tubes
  • Death expected within 48 hours
  • Prisoner status
  • Severe congestive heart failure
  • End-stage liver disease
  • End-stage renal disease
  • History of or suspected empyema involving the pleural cavity of interest
  • History of or anticipated need for pleurodesis of the pleural cavity of interest
  • Malignant pleural effusion
  • Pregnancy
  • Previous participation in this study
  • Thoracostomy tube drainage already <2 mL/kg

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2Drainage <2 mL/kgDrainage \<2 mL/kg
1No drainage thresholdNo drainage threshold
Primary Outcome Measures
NameTimeMethod
Invasive drainage procedureWithin 60 days
Secondary Outcome Measures
NameTimeMethod
Time to thoracostomy tube removalWithin 60 days
Pulmonary symptoms60 days
Mortality60 days

Trial Locations

Locations (1)

University of California, Davis, Medical Center

🇺🇸

Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath